Sorrento Therapeutics
$2.649876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.08 (-2.94%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell SRNE and other stocks, options, ETFs, and crypto commission-free!
About SRNE
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. Read More The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.
CEO
Employees
382
Headquarters
San Diego, California
Founded
2006
Market Cap
475.46M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.27M
High Today
$2.80
Low Today
$2.59
Open Price
$2.67
Volume
3.42M
52 Week High
$6.50
52 Week Low
$1.39
Collections
SRNE Earnings
-$0.88
-$0.59
-$0.29
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 13, Pre-Market
People Also Bought
Clovis Oncology
4,972
$9.28
-1.69%Viking Therapeutics
38,274
$6.65
-1.19%Verastem
17,386
$2.03
+1.50%Aurinia Pharmaceuticals
11,564
$19.80
+5.83%Catalyst Pharmaceuticals
48,940
$5.25
+10.06%Geron
31,598
$1.31
+1.55%Amarin
16,082
$18.25
+3.58%Myovant Sciences
5,704
$11.38
-2.82%Corbus Pharmaceuticals
49,160
$5.68
+3.18%TG Therapeutics
5,270
$15.86
+0.51%NIO
130,735
$3.93
+4.24%Onconova Therapeutics
21,272